Congress needs to reform the FCRA’s treatment of consumer medical debt

• Key insight: Involuntary medical debt continues to impair the credit of an untold number of otherwise creditworthy Americans. Federal courts have left the door open for Congress to amend the Fair Credit Reporting Act in a way that would address the problem.
• Supporting data: A January 2026 KFF survey found that health care costs are now the top financial worry for American families — surpassing food, housing, transportation and utilities.
• Forward look: Congress should establish a distinct legal category for medical debt in the consumer reporting framework — one that reflects both the involuntary nature of the debt and the documented accuracy problems that plague medical billing.

I spent years working at the Consumer Data Industry Association — the trade organization that represents the three major credit bureaus. I know the arguments for keeping medical debt in credit reports. I’ve made some of them. So, when I tell you that the current system is broken and Congress needs to fix it, I’m not coming at this from the outside.
Last July, a federal court in the Eastern District of Texas vacated the Consumer Financial Protection Bureau’s medical debt credit reporting rule. The ruling was legally defensible — the court found the bureau had overstepped its statutory authority under the Fair Credit Reporting Act. But the legal outcome and the policy outcome are two entirely different things. The court didn’t rule that medical debt belongs on credit reports. It ruled that the CFPB didn’t have the authority to say otherwise. That distinction matters, because it points directly at Congress.

Processing Content

The Fair Credit Reporting Act was signed into law in 1970. It was designed for a world in which consumer debt was largely a matter of choice — you applied for a credit card, took out a car loan, financed a television set. The law was built around a simple premise: If you voluntarily took on debt and didn’t pay it back, creditors had a legitimate interest in knowing that. That premise still holds. It just doesn’t describe medical debt.

Nobody chooses to need emergency surgery. Nobody selects a hospital the way they select a credit card. Medical debt lands on roughly 100 million Americans, and unlike a missed car payment, it frequently reflects billing errors, insurance disputes, and administrative delays that have nothing to do with a consumer’s willingness or ability to repay anything. The CFPB’s own research found that medical debt is a poor predictor of creditworthiness relative to other types of debt — it tells lenders less than they think it does, at significant cost to the consumers who carry it.

The affordability numbers tell the rest of the story. A January 2026 KFF survey found that health care costs are now the top financial worry for American families — surpassing food, housing, transportation and utilities. Two-thirds of adults say they’re at least somewhat worried about affording health care. About half say they could not cover an unexpected medical bill of $500 out of pocket. A West Health-Gallup survey conducted last summer found that roughly 82 million Americans have already made trade-offs with their daily expenses — skipping meals, stretching prescription doses, borrowing money — just to pay for health care. These are not the behaviors of people who chose to take on debt. They are the behaviors of people trying to survive a system that was not designed to catch them.

And this is happening as the safety net shrinks. Premium costs are rising, Affordable Care Act subsidies are under pressure, and Medicaid enrollment faces new restrictions. The same households most likely to accumulate medical debt are the least insulated from the policy changes unfolding in 2026. When those bills eventually go to collections and onto credit reports, they will follow these families for years — depressing credit scores, raising borrowing costs, and closing doors on housing, employment, and financial recovery. The CFPB estimated its vacated rule would have raised credit scores for affected consumers by an average of 20 points and expanded access to mortgages for 22,000 consumers annually. That is not a rounding error in someone’s life.

The credit reporting industry knows this. The three major bureaus voluntarily removed medical collection debts under $500 and paid medical debts from credit reports in 2022 — an acknowledgment that at least some of this data was doing more harm than good in the system. That was the right instinct, but voluntary half measures are not a durable policy. The Texas ruling has now foreclosed the regulatory path. What remains is legislation.

The case for a targeted Fair Credit Reporting Act amendment is straightforward. Congress should establish a distinct legal category for medical debt in the consumer reporting framework — one that reflects both the involuntary nature of the debt and the documented accuracy problems that plague medical billing. This does not mean consumers can ignore medical bills with impunity. It means the credit reporting system should be calibrated around predictive accuracy, not collections leverage.

There are real concerns on the industry side, and they deserve honest engagement. Lenders have a legitimate interest in complete credit information. Any reform has to preserve the integrity of the underlying data architecture, maintain appropriate consumer dispute mechanisms and avoid creating perverse incentives that make medical credit harder to extend. These are solvable problems. They are not arguments for doing nothing.

The political moment is also more favorable than it appears. Medical debt is a bipartisan grievance. Republican state legislators have backed medical debt protections in states including Virginia and Colorado. The issue crosscuts ideology because it crosscuts demographics — it hits rural communities as hard as urban ones, working families as hard as the uninsured. When two-thirds of Americans — across party lines — say health care costs are their top financial fear, Congress has both the mandate and the mechanism to act.

The Texas court ruling sent a clear message: If you want to change how medical debt is handled in the credit reporting system, the vehicle is Congress and the statute is the Fair Credit Reporting Act. That message should be heard not as a dead end but as a redirect. Fifty-five years after the law was signed, the consumer credit landscape looks nothing like 1970. It should reflect the world it actually governs.

I’ve sat on the industry side of this debate. I understand why the credit reporting ecosystem resists changes that could affect data completeness or introduce new liability exposure. But I also know that a system built on data that doesn’t accurately predict behavior isn’t serving lenders any better than consumers. The case for reform is as much about the quality of credit information as it is about consumer protection. Congress should make it.